BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28934750)

  • 1. Frontotemporal Dementia Caused by the P301L Mutation in the MAPT Gene: Clinicopathological Features of 13 Cases from the Same Geographical Origin in Barcelona, Spain.
    Borrego-Écija S; Morgado J; Palencia-Madrid L; Grau-Rivera O; Reñé R; Hernández I; Almenar C; Balasa M; Antonell A; Molinuevo JL; Lladó A; Martínez de Pancorbo M; Gelpi E; Sánchez-Valle R
    Dement Geriatr Cogn Disord; 2017; 44(3-4):213-221. PubMed ID: 28934750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
    Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
    Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique common ancestor introduced P301L mutation in MAPT gene in frontotemporal dementia patients from Barcelona (Baix Llobregat, Spain).
    Palencia-Madrid L; Sánchez-Valle R; Fernández de Retana I; Borrego S; Grau-Rivera O; Reñé R; Hernández I; Almenar C; Rossi G; Caroppo P; Redaelli V; Le Ber I; Camuzat A; Brice A; Antonell A; Balasa M; Gelpi E; Lladó A; de Pancorbo MM
    Neurobiol Aging; 2019 Dec; 84():236.e9-236.e15. PubMed ID: 31537395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
    Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
    Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.
    Gatto EM; Allegri RF; Da Prat G; Chrem Mendez P; Hanna DS; Dorschner MO; Surace EI; Zabetian CP; Mata IF
    Neurobiol Aging; 2017 May; 53():195.e11-195.e17. PubMed ID: 28268100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration.
    Giannini LA; Mol MO; Rajicic A; van Buuren R; Sarkar L; Arezoumandan S; Ohm DT; Irwin DJ; Rozemuller AJ; ; van Swieten JC; Seelaar H
    Acta Neuropathol Commun; 2023 Aug; 11(1):126. PubMed ID: 37533060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings.
    Erro ME; Zelaya MV; Mendioroz M; Larumbe R; Ortega-Cubero S; Lanciego JL; Lladó A; Cabada T; Tuñón T; García-Bragado F; Luquin MR; Pastor P; Ferrer I
    J Neurol; 2019 Oct; 266(10):2396-2405. PubMed ID: 31190169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration.
    Giannini LAA; Ohm DT; Rozemuller AJM; Dratch L; Suh E; van Deerlin VM; Trojanowski JQ; Lee EB; van Swieten JC; Grossman M; Seelaar H; Irwin DJ;
    Acta Neuropathol; 2022 Dec; 144(6):1065-1084. PubMed ID: 36066634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.
    Ikeda A; Shimada H; Nishioka K; Takanashi M; Hayashida A; Li Y; Yoshino H; Funayama M; Ueno Y; Hatano T; Sahara N; Suhara T; Higuchi M; Hattori N
    Mov Disord; 2019 Apr; 34(4):568-574. PubMed ID: 30773680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum.
    Gossye H; Van Mossevelde S; Sieben A; Bjerke M; Hendrickx Van de Craen E; van der Zee J; De Deyn PP; De Bleecker J; Versijpt J; van den Ende J; Deryck O; Bourgeois P; Bier JC; Goethals M; Vandenberghe R; Engelborghs S; Van Broeckhoven C
    Brain; 2023 Apr; 146(4):1624-1636. PubMed ID: 36171642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.
    Wren MC; Zhao J; Liu CC; Murray ME; Atagi Y; Davis MD; Fu Y; Okano HJ; Ogaki K; Strongosky AJ; Tacik P; Rademakers R; Ross OA; Dickson DW; Wszolek ZK; Kanekiyo T; Bu G
    Mol Neurodegener; 2015 Sep; 10():46. PubMed ID: 26373282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXP2 Expression in Frontotemporal Lobar Degeneration-Tau.
    López-González I; Palmeira A; Aso E; Carmona M; Fernandez L; Ferrer I
    J Alzheimers Dis; 2016 Sep; 54(2):471-5. PubMed ID: 27497476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD.
    van der Zee J; Rademakers R; Engelborghs S; Gijselinck I; Bogaerts V; Vandenberghe R; Santens P; Caekebeke J; De Pooter T; Peeters K; Lübke U; Van den Broeck M; Martin JJ; Cruts M; De Deyn PP; Van Broeckhoven C; Dermaut B
    Brain; 2006 Apr; 129(Pt 4):841-52. PubMed ID: 16495329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous MAPT R406W mutation causing FTDP phenotype: A unique instance of a unique mutation.
    Behnam M; Ghorbani F; Shin JH; Kim DS; Jang H; Nouri N; Sedghi M; Salehi M; Ansari B; Basiri K
    Gene; 2015 Oct; 570(1):150-2. PubMed ID: 26086902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic variation in hereditary frontotemporal dementia with tau mutations.
    van Swieten JC; Stevens M; Rosso SM; Rizzu P; Joosse M; de Koning I; Kamphorst W; Ravid R; Spillantini MG; Niermeijer ; Heutink P
    Ann Neurol; 1999 Oct; 46(4):617-26. PubMed ID: 10514099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
    Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
    Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two pathologically confirmed cases of novel mutations in the MAPT gene causing frontotemporal dementia.
    Shafei R; Woollacott IOC; Mummery CJ; Bocchetta M; Guerreiro R; Bras J; Warren JD; Lashley T; Jaunmuktane Z; Rohrer JD
    Neurobiol Aging; 2020 Mar; 87():141.e15-141.e20. PubMed ID: 31870644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation.
    Su Y; Fu J; Yu J; Zhao Q; Guan Y; Zuo C; Li M; Tan H; Cheng X
    J Alzheimers Dis; 2020; 76(1):149-157. PubMed ID: 32444551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau pathology in a family with dementia and a P301L mutation in tau.
    Mirra SS; Murrell JR; Gearing M; Spillantini MG; Goedert M; Crowther RA; Levey AI; Jones R; Green J; Shoffner JM; Wainer BH; Schmidt ML; Trojanowski JQ; Ghetti B
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):335-45. PubMed ID: 10218629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372G.
    Tacik P; DeTure MA; Carlomagno Y; Lin WL; Murray ME; Baker MC; Josephs KA; Boeve BF; Wszolek ZK; Graff-Radford NR; Parisi JE; Petrucelli L; Rademakers R; Isaacson RS; Heilman KM; Petersen RC; Dickson DW; Kouri N
    Brain Pathol; 2017 Sep; 27(5):612-626. PubMed ID: 27529406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.